Our overriding goal is to find new ways for the prevention and treatment of type 1 and type 2 diabetes. This year’s conference will focus on the metabolic connection between cancer, diabetes and other components of metabolic dysfunction. The world’s leading faculty in this area will thus enrich this year’s program. Following our long-standing tradition, we will feature again the HelDI (Helmholtz Young Investigator in Diabetes) competition with selected talks by rising stars in the field of diabetes, and the presentation of the Helmholtz Diabetes Lecture. In 2019, Daniel J. Drucker (Toronto) will receive this award in recognition of his life-time achievements.
Further information can be found here.